Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in Osteopenic Postmenopausal Women
NCT00345644Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risedronate in osteopenia, sponsored by Sanofi. Started Mar 2006; status: completed.
02
Drugs
risedronate
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00345644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345644.